Hyde Jonathan R, Kamangar Elham, Ladenheim Alexander E, Cooke David T
Division of General Thoracic Surgery, Department of Surgery, University of California, Davis Health, Sacramento, California.
Department of Pathology and Laboratory Medicine, University of California, Davis Health, Sacramento, California.
Ann Thorac Surg Short Rep. 2022 Oct 18;1(1):137-139. doi: 10.1016/j.atssr.2022.10.006. eCollection 2023 Mar.
Bronchiolar adenoma is a benign neoplastic process thought to be derived from the bronchiolar epithelium. Particularly in small biopsy specimens, this entity can mimic lung cancer with important implications for management. We report the case of a 33-year-old man with a right upper lobe lung nodule, with initial biopsy identifying an adenocarcinoma with gene fusion. After being considered for neoadjuvant targeted therapy trials, the patient underwent a lobectomy. On postoperative histologic evaluation, the patient was found to have a benign bronchiolar adenoma.
细支气管腺瘤是一种良性肿瘤性病变,被认为起源于细支气管上皮。特别是在小活检标本中,该病变可酷似肺癌,这对治疗具有重要意义。我们报告一例33岁男性患者,其右上叶肺结节最初活检诊断为伴有基因融合的腺癌。在考虑参加新辅助靶向治疗试验后,该患者接受了肺叶切除术。术后组织学评估发现,患者患的是良性细支气管腺瘤。